XAGE — Longevity Health Holdings Cashflow Statement
0.000.00%
Last trade - 00:00- $0.74m
- $0.54m
- $1.91m
Annual cashflow statement for Longevity Health Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -6.48 | -9.05 | -16.2 | -10.7 | -6.91 |
| Depreciation | |||||
| Non-Cash Items | 4.26 | 3.19 | 11.2 | 5.51 | 0.741 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.953 | 2.34 | -3.42 | 0.669 | 2.76 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -1.18 | -3.43 | -8.35 | -4.39 | -3.33 |
| Capital Expenditures | -0.007 | -0.007 | -0.03 | — | -0.014 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | — | -0.749 | -0.15 |
| Acquisition of Business | |||||
| Cash from Investing Activities | -0.007 | -0.007 | -0.03 | -0.749 | -0.164 |
| Financing Cash Flow Items | -0.166 | -0.403 | 12.5 | -0.086 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1.2 | 3.55 | 11.2 | 2.38 | 4.04 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.011 | 0.116 | 2.78 | -2.76 | 0.55 |